Crime ring busted for selling counterfeit e-cigarettes in Ukraine

Aug.29.2024
Crime ring busted for selling counterfeit e-cigarettes in Ukraine
A criminal gang selling counterfeit e-cigarettes worth over $120,000 was busted in Lviv, Ukraine, by the Security Bureau.

According to a report by UNN on August 27, a criminal group suspected of selling counterfeit e-cigarettes was recently busted in the Lviv region of Ukraine.


The Economic Security Bureau of Ukraine (Bureau of Economic Security, BES) seized counterfeit e-cigarettes worth over 5 million hryvnias (approximately 120,000 USD) in a raid operation.


According to reports, the group was selling e-cigarettes without proper consumer tax labels, or using counterfeit tax labels, and did not have the necessary tobacco product wholesale or retail licenses. These illegal sales points were widespread in Lviv and its surrounding areas.


According to reports, law enforcement officers seized over 8000 polymer containers filled with e-cigarette liquid, as well as other related items such as packaging barrels, labels, ledgers, and computer equipment. The Economic Security Bureau stated that the counterfeit goods seized have a total value exceeding 5 million grivnas (approximately $120,000).


In addition, Alexander Rubin, director of the Kyiv Research Institute, pointed out that with the increasing popularity of e-cigarettes and electronic heated tobacco products, the institute's research on related products is becoming more frequent.


Since the beginning of this year, the research institute has been continuously receiving tasks to study classic tobacco products, electronic heated tobacco products (TVEN), and e-cigarette e-liquids. Each research task includes 150 to 200 samples, each of which requires detailed inspection and analysis. Recently, the popularity of e-cigarettes and their associated risks have even surpassed traditional cigarettes. This has presented us with new challenges and tasks.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Maryland middle school incident: 11-year-olds found with a THC vaping device; juvenile citations issued
Maryland middle school incident: 11-year-olds found with a THC vaping device; juvenile citations issued
The BayNet reports that on Feb. 5 at about 1:35 p.m., an 11-year-old student at Davis Middle School in Waldorf, Maryland, was found in possession of a vaping device containing THC. Further investigation found that two other 11-year-old students also possessed the same vaping device at different points during the day.
Feb.09 by 2FIRSTS.ai
Indonesia’s vape retailers adopt 21+ signage and ID verification requirements, report says
Indonesia’s vape retailers adopt 21+ signage and ID verification requirements, report says
RetailNews Asia reported that the Association of Indonesian Vape Retailers (Arvindo) has directed member stores to stop selling e-cigarettes to people under 21 and to display 21+ signage and verify customer age using valid identification.
Feb.27
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
Singapore Health Minister Ong Ye Kung receives SEATCA award for tobacco control and anti-vaping push
Singapore Health Minister Ong Ye Kung receives SEATCA award for tobacco control and anti-vaping push
SEATCA has honoured Singapore Health Minister Ong Ye Kung with its inaugural Trailblazer Award, citing Singapore’s long-standing vaping ban, stepped-up enforcement and regulatory measures, and the city-state’s role in sharing tobacco-control policy experience across ASEAN.
Feb.06 by 2FIRSTS.ai
Japan Tobacco Launches Nordic Spirit Nicotine Pouches in Japan; Nationwide Rollout Starts April 6
Japan Tobacco Launches Nordic Spirit Nicotine Pouches in Japan; Nationwide Rollout Starts April 6
Japan Tobacco (JT) has introduced the new Nordic Spirit nicotine pouch brand in Japan. The Cola Fizz Medium flavor began early sales on March 3, 2026 via the CLUB JT online shop, and will be rolled out sequentially from April 6 through nationwide channels including 7-Eleven, Lawson, and NewDays. The Berry Mix Medium flavor is expected to launch on CLUB JT around mid-March.
Mar.04 by 2FIRSTS.ai